Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.
Costanzo A, Russo F, Galluzzo M, Stingeni L, Scuderi R, Zichichi L, Papini M, Di Costanzo L, Conti A, Burlando M, Chiricozzi A, Gaiani FM, Mugheddu C, Musumeci ML, Gisondi P, Piaserico S, Dapavo P, Venturini M, Pagnanelli G, Amerio P, Potenza C, Peris K, Cantoresi F, Trevisini S, Loconsole F, Offidani A, Mercuri SR, Lora V, Prignano F, Bartezaghi M, Oliva G, Aloisi E, Orsenigo R. Costanzo A, et al. Among authors: venturini m. Acta Derm Venereol. 2021 Oct 21;101(10):adv00576. doi: 10.2340/00015555-3816. Acta Derm Venereol. 2021. PMID: 33903916 Free PMC article. Clinical Trial.
How to improve adherence to treatment in patients with mild-to-moderate psoriasis.
Piaserico S, Manfredini S, Borghi A, Gisondi P, Pazzaglia M, Stinco G, Venturini M, Conti A. Piaserico S, et al. Among authors: venturini m. G Ital Dermatol Venereol. 2018 Oct;153(5):692-697. doi: 10.23736/S0392-0488.17.05697-8. Epub 2017 Jul 11. G Ital Dermatol Venereol. 2018. PMID: 28704994 Review.
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines.
Cozzani E, Marzano AV, Caproni M, Feliciani C, Calzavara-Pinton P; Cutaneous Immunology group of SIDeMaST. Cozzani E, et al. G Ital Dermatol Venereol. 2018 Jun;153(3):305-315. doi: 10.23736/S0392-0488.18.06006-6. Epub 2018 Mar 30. G Ital Dermatol Venereol. 2018. PMID: 29600832 Free article.
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort.
Bianchi L, Caposiena Caro RD, Ganzetti G, Molinelli E, Dini V, Oranges T, Romanelli M, Fabbrocini G, Monfrecola G, Napolitano M, Egan CG, Musumeci ML, Lacarrubba F, Micali G, Passoni E, Calzavara-Pinton PG, Venturini M, Zanca A, Offidani AM. Bianchi L, et al. Among authors: venturini m. Clin Exp Dermatol. 2019 Jul;44(5):e177-e180. doi: 10.1111/ced.13861. Epub 2018 Dec 28. Clin Exp Dermatol. 2019. PMID: 30593710
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Marzano AV, et al. Among authors: venturini m. Br J Dermatol. 2021 Jan;184(1):133-140. doi: 10.1111/bjd.18983. Epub 2020 Apr 13. Br J Dermatol. 2021. PMID: 32119111 Free article.
696 results